Skip to main content

Infective endocarditis in children with heart diseases at Jakaya Kikwete Cardiac Institute, Tanzania: a cross-sectional study

Abstract

Background

Infective endocarditis (IE) in children with pre-existing heart conditions is a life-threatening disease entity associated with significant morbidity and mortality. In our cardiac setting, the management outcomes of children with IE are not well documented. We therefore aimed to document the clinical profile and treatment outcomes of children with IE attended at the Jakaya Kikwete Cardiac Institute (JKCI).

Methods

This was a hospital-based cross-sectional study with longitudinal follow-up conducted among children with IE diagnosed by Modified Duke’s Criteria at the JKCI from November 2021 to November 2023. A structured questionnaire was used to collect patients’ socio-demographic and clinical data.

Results

During the study period, 1,546 children were admitted to the JKCI. A total of 30 children with IE were enrolled, of these half (n = 16, 53%) were aged 10 to 18 years, with a median of 10 yrs (Inter quartile range, IQR: 6.5–12.2 yrs). Twelve children (40%) and nearly half (n = 14, 47%) had fever and used antibiotic therapy respectively. Majority of participants had anaemia (n = 26, 87%) and heart failure (n = 21, 70%). Nine children (30%) had positive blood cultures and S. aureus was the most frequently isolated organism (n = 7). Ten patients (33%) developed acute kidney injury (AKI), and eleven (37%) children died during the hospital stay.

Conclusion

In our setting, in-hospital mortality due to IE among children with heart diseases is high. Heart failure and anaemia were the common presentations of IE. Furthermore, AKI was observed to be the leading in-hospital non-cardiac complication.

Peer Review reports

Introduction

Infective endocarditis (IE) is an uncommon but serious microbial infection of the endocardium whose incidence ranges from 0.05 to 6.1 per 1000 children globally [1, 2]. Mortality associated with IE is reported to be higher in low- and middle- income countries compared to the developed world, however, limited studies have been conducted in these countries [3,4,5,6,7,8].

Diagnosis of IE is made by using the modified Duke’s criteria [1], however, there are challenges of early diagnosis due to non-specific symptoms at presentation such as low-grade fevers and arthralgias [9]. Nevertheless, there are reported limitations with the above criteria such as negative blood cultures results and normal echocardiographic findings despite the presence of IE [1]. Consequently, a high index of suspicion is highly required especially in patients with reported risk factors including structural heart diseases or presence of prosthetic material [6, 9,10,11].

IE with negative bacterial blood cultures have been frequently reported in various studies, this is partly attributed to antimicrobial pre-treatment which reduces the yield of blood culture up to 60% [10,11,12,13]. Other factors are limited culture techniques for growing fastidious and rare organisms especially in developing countries or intracellular organisms that cannot be cultured [1, 13]. Microorganisms such as Staphylococcus aureus and Streptococcal viridans remain the leading causative bacteria in the paediatric population [13,14,15,16].

Empirical antibiotics for IE can be initiated before the identifiable agent is recovered with several considerations such as a prior history of antibiotic use, whether the native valve or prosthetic valve is involved and if its community or hospital-acquired infection [10]. However, in some cases surgical intervention may be indicated.

Despite advancements in diagnostics, treatment and preventive measures, the affected children have been reported to suffer from several complications including heart failure, systemic embolization or renal failure [6, 10, 17].

Our centre attends children with heart diseases from different areas of the country, however, we do lack local data on IE as it is in other low-income countries. Therefore, this study aimed to determine the clinical characteristics and the outcomes of children with IE.

Methods

Study design and setting

This was a hospital-based cross-sectional study with a longitudinal follow-up conducted in a paediatric cardiology unit at the JKCI, Tanzania from November 2021 through November 2023. JKCI is a 150-bed capacity national referral and teaching centre providing specialized cardiac services for adults and children. It is the only centre offering open cardiac surgery in Tanzania with seven paediatric cardiologists and two paediatric cardiac surgeons.

Study population and inclusion criteria: All children with heart conditions aged 1 month to 18 years were admitted to the paediatric unit during the study period. Those who fulfilled the modified Duke criteria were enrolled in the study. However, those who met the “rejected IE” criteria were excluded.

Study variables and measurements

Age, sex, prior antibiotic therapy, echocardiographic (ECHO) findings (valvular/perivalvular/periprosthetic lesions characteristics of IE by transthoracic ECHO), laboratory findings, IE treatment initiation and completion, treatment regimen, observed complications (heart failure, AKI, systemic embolization) and mortality were recorded.

Echocardiographic features of IE include vegetations, defined as an oscillating or non-oscillating intracardiac mass on a valve or other cardiac structure or prosthetic materials. Other features were; intracardiac abscess, pseudoaneurysm, valvular perforation and dehiscence of prosthetic intracardiac materials [10].

Mortality and observed complications (acute kidney injury, stroke, heart failure) were determined during the follow-up over the hospital stay until discharge.

The cut-off point to define anaemia was haemoglobin levels below 11 g/dl according to WHO guideline [18]. Severe anaemia was classified as haemoglobin levels below < 7 g/dl.

Sample collection and testing

Five millilitres (mls) of blood were aseptically drawn from each enrolled child. Three mls of blood were inoculated into the BacT/Alert PF (Paediatric) bottle and the remaining 2 mls were sent for complete blood count and clinical chemistry analyses.

to conduct this study was obtained from the Ethics Review Committee of the Jakaya Kikwete Cardiac Institute (Ref.No.AB.123/307/01 C/32). Informed consent of participation in the study was obtained from the patients and /or their legal guardians and children above 7 years assent was obtained.

Data management and analysis

Data collection was done using a standardized structured questionnaire. Data entry and analysis were done using SPSS software version 23. Descriptive statistics were summarized into frequencies and proportions.

Results

In a period of two years, 1,546 children were admitted to the JKCI, and of these 30 children with IE were diagnosed. The hospital prevalence of infective endocarditis was 1.94%. Most of the children (n = 29) were found to have definite IE and the remaining one patient had probable IE (Definite, n = 29) (Fig. 1).

Fig. 1
figure 1

Flow diagram showing the recruitment of study participants and their outcomes

Out of 30 recruited children 16 (53%) were males and half (53%) were aged 10 to 18 years with a median of 10 years (IQR: 6.5–12.2 yrs). Twelve children (40%) and nearly half (n = 14, 47%) had fever and used antibiotic therapy respectively. The majority of patients had anaemia (n = 26, 87%), of which six children had severe form. About a third of the study participants (n = 10, 34%) had acyanotic congenital heart disease and a quarter (n = 8, 26%) had rheumatic heart disease. All children had blood cultures done, however, only nine (30%) yielded positive results with S. aureus as the predominant isolate (n = 7). Out of twenty-nine participants who had vegetations, nearly two-thirds (n = 19, 63%) had measured less than 10 mm and about half (n = 15, 50%) were located on the left side of the heart. Nonetheless, six out of 30 children presented with glomerulonephritis. All children were on antibiotic therapy, however, two-thirds of them (n = 21, 70%) were on antibiotic therapy for more than 6 weeks. Furthermore, only one child underwent surgery due to heart failure and uncontrolled infection (Table 1).

Table 1 Clinical characteristics of children with infective endocarditis at JKCI in Tanzania, 2021–2023 (N = 30)

Heart failure was the commonest complication (n = 21, 70%) followed by acute kidney injury (n = 10, 33%) and systemic embolization (17%). About two-thirds of study participants (73%) spent more than 28 days in the ward and eleven children (37%) died during the hospital stay (Table 2).

Table 2 Clinical complications and outcomes of children with infective endocarditis at JKCI in Tanzania, 2021–2023 (N = 30)

Out of eleven children who died, eight and seven of them had vegetation of more than 10 mm, on the left side of the heart respectively. Eight children had significantly elevated white cell count. In a further review of causes of death, eight patients died of multi-organ failure (Table 3).

Table 3 Socio-demographics and clinical characteristics of demised children with infective endocarditis at JKCI in Tanzania, 2021–2023 (N = 11)

Discussion

This study demonstrates the clinical characteristics and hospital outcomes of the children with IE admitted at JKCI. In two years, 30 children were admitted due to IE, heart failure and anaemia were the common presenting clinical features. A significant number of children had prolonged hospital stays with a mortality of approximately 37%.

The present study shows significantly high in-hospital mortality despite timely management. Our finding is comparable to various studies conducted in developing countries, where high mortality was also reported [7, 13, 19,20,21]. On the contrary, a study conducted in Addis Ababa [11] reported a low fatality rate, the discrepancy can probably be differences in patients’ clinical presentations. In this cohort, a great number of demised children presented in critically ill states with multi-organ involvement and needed admission to the intensive care unit (ICU). The majority of the IE lesions (vegetations) in children who died were either large or located on the left side of the heart, these features reported to predict poor outcome among the affected children [1].

Diagnosis of IE needs a high index of suspicion especially for those with risk factors presenting with fever. A significant number of our patients presented with heart failure and fever upon admission. Fever and congestive heart failure are reported to be the most frequent clinical presentations in patients with IE [1]. This aligns with previous studies [10, 22, 23] where fever and congestive heart failure are often reported.

As in previous reports [3, 5], IE reported to follow bimodal age distribution thus peaks in infancy and late adolescence. In the present study, half of the children with IE were aged 10 years and above. We observed a few numbers of children in the neonatal group since children below 28 days are cared for in the neonatal unit and our cardiac paediatric ward, we only admit neonates when scheduled for cardiac surgery.

In this study, blood culture-negative IE (BCNIE) was significant, only one-third of children had positive blood culture, with S. aureus being the most common organism, which is comparable to what is reported in the literature [1, 10]. A significant BCNIE in our study can be explained by a few reasons, including prior antibiotic use, as nearly half of our patients were on antibiotics before admission. Another reason is limited culture techniques for growing fastidious and rare organisms especially in developing countries.

We also observed a substantial number of children developing acute kidney injury (AKI), which is one of the reported non-cardiac complications. These children were those who needed urgent intensive care, however, none required needed dialysis treatment. The above findings were comparable with other previous reports [3, 24].

This study had some limitations, including the small number of participants, which limits further statistical analysis. Secondly, due to financial constraints, the studied patients did not meet the standard of at least three sets for blood culture analysis as per modified Duke’s criteria.

Conclusion

Infective endocarditis though occurs infrequently, the present study demonstrates its high in- hospital mortality among the affected children. Heart failure and anemia were the common presenting clinical features. Furthermore, AKI was the leading in-hospital non-cardiac complication.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

AKI:

Acute kidney injury

BCNIE:

Blood culture negative infective endocarditis

CHD:

Congenital heart disease

ECHO:

Echocardiography

ESC:

European society of cardiology

IE:

Infective endocarditis

ICU:

Intensive care unit

PDA:

Patent ductus arteriosus

RHD:

Rheumatic heart disease

TOF:

Tetralogy of Fallot

VSD:

Ventricular septal defect

References

  1. Delgado V, Marsan NA, Waha S, De, Germany TFC, Bonaros N, Brida M et al. 2023 ESC guidelines for the management of endocarditis developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European. 2023;1–95.

  2. Elder RW. T h e Chang I n g epidemiology of Pediatric Endocarditis. Infect Dis Clin NA. 2015;29(3):513–24.

    Article  Google Scholar 

  3. Gupta S, Sakhuja A, Mcgrath E, Asmar B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000–2010 in the United States. 2016;(September):1–6.

  4. Martin JM, Neches WH, Wald ER. Infective Endocarditis: 35 Years of Experience at a Children ’ s Hospital. 1992;669–75.

  5. Rushani D, Kaufman JS, Ionescu-ittu R, Mackie AS, Pilote L, Therrien J et al. Epidemiol Prev Infective Endocarditis Child Congenital Disease. 2013;1412–20.

  6. Daphna Marom SA, Samra, Zmira BE. Infective endocarditis in previously healthy children with structurally normal hearts. 2013;(34):1415–21.

  7. Bitar FF, Jawdi RA, Dbaibo GS, Yunis KA, Gharzeddine W, Obeid M. Paediatric infective endocarditis: 19-year experience at a tertiary care hospital in a developing country. 2000;(89):427–30.

  8. Hugo-hamman CT, Oxon MA, Sa DCH, Moor MMA, De, Wits B, Sa FCP. Infective Endocarditis South Afr Child. 1989;35(August):155–8.

    Google Scholar 

  9. Robert M, Kliegman, Bonita F, Stanton JW. St Geme III NFSM. Nelson Textbook of Pediatrics twentieth Edition. 2015. 2304, 2379 p.

  10. Habib G, France C, Grazia M, France JC, Del F, El G, et al. 2015 ESC guidelines for the management of infective endocarditis the Task Force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by. European Association for Cardio-Thoracic Surgery; 2015.

  11. Tamirat Moges E, Gedlu P, Isaakidis A, Kumar R, Van Den Berge M, Khogali. Amha Mekasha SGH. Infective endocarditis in Ethiopian children: a hospital based review of cases in Addis Ababa. 2015;8688:1–10.

  12. Pecoraro AJ, Doubell AF. Infective endocarditis in South Africa. 2020;10(I):252–61.

  13. Letaief A, Boughzala E, Kaabia N, Ernez S. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. 2007;430–3.

  14. Johnson BDH, Rosenthal A. A Forty-year Review of Bacterial Endocarditis in Infancy and Childhood. 1972.

  15. Slipczuk L, Codolosa JN, Davila CD, Romero-corral A, Yun J, Gregg S et al. Infective Endocarditis Epidemiol over Five Decades: Syst Rev. 2013;8(12).

  16. Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics Child Hospitalized Infective Endocarditis. 2015;865–70.

  17. Noubiap JJ, Nkeck JR, Kwondom BS, Nyaga UF. Articles Epidemiology of infective endocarditis in Africa: a systematic review and meta-analysis. 4–6.

  18. World Health Organization. Nutritional anaemias: Tools for effective prevention and control. 2017.

  19. Mutagaywa RK, Vroon JC, Fundikira L, Wind AM, Kunambi P, Manyahi J et al. Infective endocarditis in developing countries: an update. Front Cardiovasc Med. 2022;01–14.

  20. Koegelenberg CFN, Doubell AF, Orth H, Reuter H. Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study. 2003;217–25.

  21. Ba DM, Mboup MC, Zeba N, Dia K, Fall AN, Fall F et al. Infective endocarditis in principal Hospital of Dakar: a retrospective study of 42 cases over 10 years. 2017;8688:1–7.

  22. Yameogo NV, Kologo KJ, Yameogo AA, Yonaba C, Millogo GRC, Kissou SA, Toguyeni BJY, Samadoulougou AK, Pignatelli S, Simpore J. PZ. Infective endocarditis in sub-saharan African children, cross-sectional study about 19 cases in Ouagadougou at Burkina Faso N.V. Ann Cardiol Angeiol (Paris). 2013;3–6.

  23. Baragou S, Pessinaba S, Simwetare MF, Oloude-kakpovi EN, Dossim P. Infectious endocarditis in Sub-saharan Africa: epidemic-clinical aspects, evolutionary and prognostic : Multicentre Study on 81 cases followed over 1 year in Lomé. (Togo). 2020;5–9.

  24. Alkhouli M, Alqahtani F, Alhajji M, Berzingi CO, Sohail MR. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States. Mayo Clin Proc. 2019;1–9.

Download references

Acknowledgements

We are grateful to all the doctors and nurses who looked after the patients recruited in this study.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

ZEK, ANS and FFF were involved in conceptualization. ZEK wrote the first manuscript draft. DAN, NGM, ANS, FFF and SDK provided contributions in reviewing the manuscript. All authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Zawadi Edward Kalezi.

Ethics declarations

Ethical approval and consent to participate

Ethical approval to conduct the study was obtained from Ethics Review Committee of the Jakaya Kikwete Cardiac Institute (Ref.No.AB.123/307/01 C/32). All patients received treatment as per standard Institutional policies. We are confirming that all methods were carried out per relevant guidelines and regulations. Informed consent of participation in the study was obtained from the patients and /or their legal guardians and the children above 7 years, assent was obtained if they agreed to participate in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalezi, Z.E., Simbila, A.N., Nkya, D.A. et al. Infective endocarditis in children with heart diseases at Jakaya Kikwete Cardiac Institute, Tanzania: a cross-sectional study. BMC Pediatr 24, 612 (2024). https://doi.org/10.1186/s12887-024-05091-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-05091-5

Keywords